MCID: EXT010
MIFTS: 51

Extramedullary Plasmacytoma

Categories: Blood diseases, Cancer diseases

Aliases & Classifications for Extramedullary Plasmacytoma

MalaCards integrated aliases for Extramedullary Plasmacytoma:

Name: Extramedullary Plasmacytoma 12 15 74
Plasmacytoma, Extramedullary 12
Extraosseous Plasmacytoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3720
NCIt 51 C4002
SNOMED-CT 69 10639003
ICD10 34 C90.2 C90.20
UMLS 74 C0278619

Summaries for Extramedullary Plasmacytoma

MalaCards based summary : Extramedullary Plasmacytoma, also known as plasmacytoma, extramedullary, is related to plasmacytoma and solitary osseous plasmacytoma. An important gene associated with Extramedullary Plasmacytoma is B2M (Beta-2-Microglobulin), and among its related pathways/superpathways are Innate Immune System and GPCR Pathway. The drugs Bortezomib and Dexamethasone acetate have been mentioned in the context of this disorder. Affiliated tissues include bone, colon and bone marrow, and related phenotypes are cardiovascular system and cellular

Related Diseases for Extramedullary Plasmacytoma

Diseases related to Extramedullary Plasmacytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 159)
# Related Disease Score Top Affiliating Genes
1 plasmacytoma 33.1 B2M IL2 IL6
2 solitary osseous plasmacytoma 30.9 B2M MYOM2
3 marginal zone b-cell lymphoma 30.1 BCL2 CCND1
4 myeloma, multiple 29.9 B2M CCND1 IL2 IL6 MYOM2
5 poems syndrome 29.8 IL6 MYOM2
6 human immunodeficiency virus infectious disease 29.5 B2M IL2 IL6
7 acquired immunodeficiency syndrome 29.5 B2M IL2 IL6
8 leukemia, chronic lymphocytic 29.5 B2M BCL2 CCND1 IL2
9 extramedullary soft tissue plasmacytoma 10.4
10 lymphoma 10.3
11 amyloidosis 10.3
12 lymphoma, small cleaved-cell, diffuse 10.2 BCL2 CCND1
13 indolent myeloma 10.2 B2M MYOM2
14 intravascular large b-cell lymphoma 10.2 B2M BCL2
15 waldenstroem's macroglobulinemia 10.2 B2M MYOM2
16 vernal conjunctivitis 10.2 B2M IL2
17 hidradenocarcinoma 10.2 BCL2 CCND1
18 amyloid tumor 10.2 B2M MYOM2
19 non-secretory myeloma 10.2 B2M MYOM2
20 keratocystic odontogenic tumor 10.2 BCL2 CCND1
21 leukemia 10.2
22 squamous cell carcinoma 10.2
23 adenocarcinoma 10.2
24 primary central nervous system lymphoma 10.2 BCL2 IL2
25 b-cell expansion with nfkb and t-cell anergy 10.1 B2M IL2
26 syphilis 10.1 B2M BCL2
27 progressive multifocal leukoencephalopathy 10.1 BCL2 IL2
28 hypersensitivity reaction type iv disease 10.1 IL2 MYOM2
29 retroperitoneal neuroblastoma 10.1 CDKN1A IL2
30 lymphoma, mucosa-associated lymphoid type 10.1
31 intussusception 10.1
32 pancreatic cancer 10.1
33 meningioma, familial 10.1
34 crohn's disease 10.1
35 ulcerative colitis 10.1
36 colitis 10.1
37 sarcoma 10.1
38 spinal meningioma 10.1
39 patulous eustachian tube 10.1
40 obstructive jaundice 10.1
41 secretory meningioma 10.1
42 retinal cancer 10.1 CCND1 CDKN1A
43 suppressor of tumorigenicity 3 10.0 BCL2 CDKN1A
44 mycosis fungoides 10.0
45 cardiac tamponade 10.0
46 cholestasis 10.0
47 extrahepatic cholestasis 10.0
48 plasmablastic lymphoma 10.0
49 osteochondroma 10.0 BCL2 CDKN1A
50 pyelitis 10.0 B2M IL6

Graphical network of the top 20 diseases related to Extramedullary Plasmacytoma:



Diseases related to Extramedullary Plasmacytoma

Symptoms & Phenotypes for Extramedullary Plasmacytoma

MGI Mouse Phenotypes related to Extramedullary Plasmacytoma:

47 (show all 11)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.97 B2M BCL2 CCND1 CDKN1A IL2 IL6
2 cellular MP:0005384 9.95 B2M BCL2 CCND1 CDKN1A IL2 IL6
3 digestive/alimentary MP:0005381 9.93 B2M BCL2 CCND1 CDKN1A IL2 IL6
4 endocrine/exocrine gland MP:0005379 9.91 B2M BCL2 CCND1 CDKN1A IL2 IL6
5 growth/size/body region MP:0005378 9.88 B2M BCL2 CCND1 CDKN1A IL2 IL6
6 hematopoietic system MP:0005397 9.85 B2M BCL2 CCND1 CDKN1A IL2 IL6
7 immune system MP:0005387 9.8 B2M BCL2 CCND1 CDKN1A IL2 IL6
8 integument MP:0010771 9.65 B2M BCL2 CCND1 CDKN1A IL6
9 neoplasm MP:0002006 9.63 B2M BCL2 CCND1 CDKN1A IL2 IL6
10 reproductive system MP:0005389 9.43 B2M BCL2 CCND1 CDKN1A IL2 IL6
11 vision/eye MP:0005391 9.02 BCL2 CCND1 CDKN1A IL2 IL6

Drugs & Therapeutics for Extramedullary Plasmacytoma

Drugs for Extramedullary Plasmacytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 233)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bortezomib Approved, Investigational Phase 3,Phase 2,Phase 1 179324-69-7 387447 93860
2
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 1177-87-3
3
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
4
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
5
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
6
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
7
Lenalidomide Approved Phase 3,Phase 2,Phase 1 191732-72-6 216326
8
Prednisone Approved, Vet_approved Phase 3,Phase 2,Phase 1 53-03-2 5865
9
Aspirin Approved, Vet_approved Phase 3 50-78-2 2244
10
Melphalan Approved Phase 3,Phase 2 148-82-3 460612 4053
11
Iron Approved, Experimental Phase 3,Phase 1,Phase 2 7439-89-6, 15438-31-0 27284 23925
12
Darbepoetin alfa Approved, Investigational Phase 3,Phase 2 209810-58-2, 11096-26-7
13
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
14
Dalteparin Approved Phase 3 9005-49-6
15
Heparin Approved, Investigational Phase 3 9005-49-6 46507594 772
16
Ondansetron Approved Phase 3 99614-02-5 4595
17
Caspofungin Approved Phase 3,Phase 2 162808-62-0, 179463-17-3 2826718 468682
18
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
19
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2,Not Applicable 22916-47-8 4189
20
Guaifenesin Approved, Investigational, Vet_approved Phase 3,Not Applicable 93-14-1 3516
21
Dextromethorphan Approved Phase 3 125-71-3 5362449 5360696
22
Morphine Approved, Investigational Phase 3,Not Applicable 57-27-2 5288826
23
Ginseng Approved, Investigational, Nutraceutical Phase 3 50647-08-0
24
St. John's Wort Approved, Investigational, Nutraceutical Phase 3 84082-80-4
25
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
26 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
27 Hormones Phase 3,Phase 2,Phase 1
28 Antineoplastic Agents, Hormonal Phase 3,Phase 2,Phase 1
29 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1,Not Applicable
30 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1,Not Applicable
31 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1
32 Alkylating Agents Phase 3,Phase 2,Phase 1
33 Immunologic Factors Phase 3,Phase 2,Phase 1,Not Applicable
34 Antirheumatic Agents Phase 3,Phase 2,Phase 1,Not Applicable
35 Gastrointestinal Agents Phase 3,Phase 2,Phase 1
36 Proteasome Inhibitors Phase 3,Phase 1
37 Autonomic Agents Phase 3,Phase 2,Phase 1
38 glucocorticoids Phase 3,Phase 2,Phase 1
39 Immunosuppressive Agents Phase 3,Phase 2,Phase 1,Not Applicable
40 HIV Protease Inhibitors Phase 3,Phase 2,Phase 1
41 Antiemetics Phase 3,Phase 2,Phase 1
42 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1,Not Applicable
43 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
44
protease inhibitors Phase 3,Phase 2,Phase 1
45 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1,Not Applicable
46 BB 1101 Phase 3,Phase 2,Phase 1
47 Anti-Inflammatory Agents Phase 3,Phase 2,Phase 1
48 Hormone Antagonists Phase 3,Phase 2,Phase 1
49 Excitatory Amino Acids Phase 3
50 Anesthetics Phase 3

Interventional clinical trials:

(show top 50) (show all 75)
# Name Status NCT ID Phase Drugs
1 CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma Unknown status NCT02336386 Phase 3 CDD;CDD Plus Bortezomib
2 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
3 A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. Completed NCT00405756 Phase 3 Lenalidomide: Double-blind Induction;Melphalan;Prednisone;Aspirin;Placebo;Lenalidomide: Double-blind Maintenance;Lenalidomide: Open-label
4 A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma Completed NCT00424047 Phase 3 CC-5013 plus dexamethasone;Dexamethasone plus Placebo
5 A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma Completed NCT00478777 Phase 3 Lenalidomide;dexamethasone
6 A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma Completed NCT00622336 Phase 3 Lenalidomide
7 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
8 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
9 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
10 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
11 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
12 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
13 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
14 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
15 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
16 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
17 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
18 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
19 Beta Alethine in Treating Patients With Myeloma Unknown status NCT00006466 Phase 1, Phase 2 beta alethine
20 Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma Completed NCT01478048 Phase 2 Bortezomib;Dexamethasone;Dexamethasone;Dexamethasone;Dexamethasone
21 Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00489203 Phase 2 beclomethasone dipropionate;placebo;tacrolimus;methotrexate
22 Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy Completed NCT00416624 Phase 2 darbepoetin alfa;epoetin alfa
23 SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant Completed NCT00002657 Phase 2 cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;methotrexate;prednisone;vincristine sulfate
24 Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer Completed NCT00823524 Phase 1, Phase 2
25 Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer Completed NCT00255749 Phase 2
26 Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer Completed NCT00002504 Phase 2
27 Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00245037 Phase 1, Phase 2 busulfan;cyclosporine;fludarabine phosphate;mycophenolate mofetil;Granulocyte colony-stimulating factor (G-CSF);Phenytoin;Methotrexate
28 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer Completed NCT00003406 Phase 1, Phase 2 carboplatin;docetaxel;ifosfamide
29 Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant Completed NCT00110045 Phase 2 caspofungin acetate
30 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
31 Non-Ablative Allo HSCT For Hematologic Malignancies or SAA Completed NCT00006379 Phase 2 cyclophosphamide;fludarabine phosphate
32 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00005804 Phase 2 cyclophosphamide
33 Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer Completed NCT00006225 Phase 1, Phase 2
34 Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation Completed NCT00005606 Phase 2
35 Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia Recruiting NCT02547662 Phase 2 Dexamethasone;Ixazomib Citrate;Pomalidomide
36 Short Course Daratumumab in Patients With Multiple Myeloma Recruiting NCT03490344 Phase 2 Daratumumab;Lenalidomide
37 Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma Active, not recruiting NCT01849783 Phase 2 dexamethasone;cisplatin;doxorubicin;cyclophosphamide;etoposide;bortezomib;thalidomide;melphalan
38 S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma Terminated NCT00109889 Phase 2
39 Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Terminated NCT00337506 Phase 2 Dexamethasone;velcade
40 Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Withdrawn NCT01101412 Phase 1, Phase 2 Edetate Calcium Disodium;Ethanol;Trimethoprim-sulfamethoxazole
41 Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer Unknown status NCT00004036 Phase 1 amifostine trihydrate;carboplatin;cyclophosphamide
42 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Completed NCT00890747 Phase 1 sunitinib malate
43 Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction Completed NCT00025415 Phase 1 imatinib mesylate
44 Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone Completed NCT01241292 Phase 1
45 PS-341 in Treating Patients With Advanced Cancer Completed NCT00006362 Phase 1 bortezomib
46 Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy Completed NCT00005634 Phase 1 vorinostat
47 Decitabine in Treating Patients With Melanoma or Other Advanced Cancer Completed NCT00002980 Phase 1 decitabine
48 Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer Completed NCT00003451 Phase 1
49 Combination Chemotherapy in Treating Patients With Advanced Cancer Completed NCT00003331 Phase 1 fluorouracil;leucovorin calcium;topotecan hydrochloride
50 Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer Completed NCT00003082 Phase 1

Search NIH Clinical Center for Extramedullary Plasmacytoma

Genetic Tests for Extramedullary Plasmacytoma

Anatomical Context for Extramedullary Plasmacytoma

MalaCards organs/tissues related to Extramedullary Plasmacytoma:

42
Bone, Colon, Bone Marrow, B Cells, Breast, Thyroid, Liver

Publications for Extramedullary Plasmacytoma

Articles related to Extramedullary Plasmacytoma:

(show top 50) (show all 575)
# Title Authors Year
1
Endobronchial Obstruction by a Solitary Extramedullary Plasmacytoma With Light-chain Amyloidosis. ( 30908398 )
2019
2
Solitary extramedullary plasmacytoma of the rectum complicating ulcerative colitis. ( 30238285 )
2019
3
Crohn's Disease Accompanied with Small Intestinal Extramedullary Plasmacytoma. ( 30918171 )
2019
4
Solitary extramedullary plasmacytoma of palatine tonsil - a rare albeit possible entity. ( 30608059 )
2019
5
Extramedullary plasmacytoma of the right main bronchus. ( 30682355 )
2019
6
Extramedullary plasmacytoma of tonsil: an unusual site. ( 30706889 )
2019
7
Refractory ascites as a presenting feature of extramedullary plasmacytoma in an end-stage renal disease patient with HIV infection. ( 30838169 )
2019
8
Relapsed multiple myeloma manifesting as extramedullary plasmacytoma of the breast: Imaging findings. ( 30891107 )
2019
9
A Case Report of Solitary Extramedullary Plasmacytoma of the Cricoid Cartilage Diagnosed After Total Thyroidectomy. ( 30966804 )
2019
10
A Rare Case of Extramedullary Plasmacytoma Presenting as Massive Upper Gastrointestinal Bleeding. ( 30972272 )
2019
11
68Ga CXCR-4 PET/CT Imaging in an Atypical Case of Extramedullary Plasmacytoma Mimicking as Renal Cell Carcinoma. ( 30985424 )
2019
12
Extramedullary plasmacytoma of the stomach. ( 31042583 )
2019
13
Diagnosis of solitary extramedullary plasmacytoma located in the nasopharynx in a patient with acquired angioedema. ( 30618535 )
2018
14
A Case of Multiple Myeloma Associated with Extramedullary Plasmacytoma of the Gallbladder Manifesting as Acute Cholecystitis. ( 30050743 )
2018
15
Extramedullary plasmacytoma: rare neoplasm of parotid gland. ( 29301803 )
2018
16
Extramedullary plasmacytoma. ( 29496243 )
2018
17
Extramedullary plasmacytoma of the trachea: A case report and review of the literature. ( 29504982 )
2018
18
Treatment of relapsed multiple myeloma complicated by cardiac extramedullary plasmacytoma with D-PACE chemotherapy. ( 29523615 )
2018
19
Atypical Presentation of Extramedullary Plasmacytoma. ( 29559881 )
2018
20
Primary extramedullary plasmacytoma of the sigmoid colon with perforation: a case report. ( 29619633 )
2018
21
Gastrointestinal manifestations of extramedullary plasmacytoma: a narrative review and illustrative case reports. ( 29692194 )
2018
22
Five cases of orbital extramedullary plasmacytoma: diagnosis and management of an aggressive malignancy. ( 29985709 )
2018
23
Extramedullary Plasmacytoma of the Pancreas Complicated with Left-Sided Portal Hypertension-a Case Report and Literature Review. ( 30033507 )
2018
24
Extramedullary plasmacytoma of the larynx: Literature review and report of a case who subsequently developed acute myeloid leukemia. ( 30127889 )
2018
25
Concomitant Extramedullary Plasmacytoma in the Oropharynx and Hypopharyngeal Squamous Cell Carcinoma. ( 30155331 )
2018
26
Pancreatic Extramedullary Plasmacytoma Presenting as a Pancreatic Mass. ( 30262989 )
2018
27
Solitary Extramedullary Plasmacytoma Mimicking Acute Subdural Hematoma. ( 30268553 )
2018
28
Primary solitary extramedullary plasmacytoma progressing to multiple bone plasmacytomas: a rare condition with therapeutic dilemmas. ( 30335051 )
2018
29
Retroperitoneal extramedullary plasmacytoma: A case report and review of the literature. ( 30431616 )
2018
30
Sudden and unexpected death due to intracranial sellar extramedullary plasmacytoma. ( 30503990 )
2018
31
Secondary extramedullary plasmacytoma of sigmoid colon in a patient with multiple myeloma: a case report. ( 30583721 )
2018
32
Pattern of care and impact of prognostic factors on the outcome of head and neck extramedullary plasmacytoma: a systematic review and individual patient data analysis of 315 cases. ( 29224044 )
2018
33
Extramedullary plasmacytoma of the testis: A case report. ( 29204364 )
2018
34
Collet-Sicard Syndrome Attributable to Extramedullary Plasmacytoma of the Jugular Foramen. ( 29191538 )
2018
35
Solitary Extramedullary Plasmacytoma of the Orbital Apex and Dura Masquerading as Idiopathic Inflammation. ( 26226234 )
2017
36
Effect of definitive radiotherapy on the long-term outcome in patients with solitary extramedullary plasmacytoma. ( 26450521 )
2017
37
Incomplete Colonic Obstruction Caused by Extramedullary Plasmacytoma. ( 27613261 )
2017
38
Unusual Cause of Sphenoidal Sinus Mass: Extramedullary Plasmacytoma. ( 27779089 )
2017
39
Multiple Extramedullary Plasmacytoma in a Setting of Complete Bone Marrow Remission: Food for Thought. ( 29340123 )
2017
40
Extramedullary plasmacytoma occuring in ileocecum: A case report and literature review. ( 29390503 )
2017
41
Solitary Extramedullary Plasmacytoma of the Cricoid Cartilage-Case Report. ( 29230383 )
2017
42
Extramedullary plasmacytoma of the testicle. ( 29205163 )
2017
43
Management of extramedullary plasmacytoma: Role of radiotherapy and prognostic factor analysis in 55 patients. ( 29142463 )
2017
44
Primary extramedullary plasmacytoma mimicking oral lichen planus. ( 28944756 )
2017
45
Uterine Extramedullary Plasmacytoma as a Primary Manifestation of Multiple Myeloma. ( 28834996 )
2017
46
Extramedullary plasmacytoma in the airway of an HIV-positive child. ( 28834349 )
2017
47
Strategy for the treatment and follow-up of sinonasal solitary extramedullary plasmacytoma: a case series. ( 28793931 )
2017
48
Extramedullary plasmacytoma mimicking pancreatic cancer: A case report and literature review. ( 28663530 )
2017
49
Clinical findings in 25 patients with sinonasal or nasopharyngeal extramedullary plasmacytoma in a four-decade single-centre series. ( 28537101 )
2017
50
Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment. ( 28507591 )
2017

Variations for Extramedullary Plasmacytoma

Expression for Extramedullary Plasmacytoma

Search GEO for disease gene expression data for Extramedullary Plasmacytoma.

Pathways for Extramedullary Plasmacytoma

Pathways related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

(show top 50) (show all 51)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.77 B2M BCL2 CCND1 CDKN1A IL2 IL6
2
Show member pathways
13.48 BCL2 CCND1 CDKN1A IL2 IL6
3
Show member pathways
13.19 BCL2 CCND1 CDKN1A IL2 IL6
4
Show member pathways
12.91 B2M BCL2 CCND1 CDKN1A IL2 IL6
5
Show member pathways
12.69 B2M CCND1 IL2 IL6
6
Show member pathways
12.69 B2M BCL2 CCND1 CDKN1A IL6
7
Show member pathways
12.64 BCL2 CCND1 CDKN1A IL2 IL6
8
Show member pathways
12.59 CCND1 CDKN1A IL2 IL6
9
Show member pathways
12.51 BCL2 CCND1 CDKN1A IL6
10
Show member pathways
12.42 BCL2 CCND1 CDKN1A
11
Show member pathways
12.42 BCL2 IL2 IL6
12 12.38 BCL2 CCND1 CDKN1A IL2 IL6
13
Show member pathways
12.37 BCL2 CDKN1A IL2 IL6
14 12.34 BCL2 CCND1 CDKN1A
15
Show member pathways
12.22 BCL2 CCND1 CDKN1A
16
Show member pathways
12.1 BCL2 CCND1 CDKN1A
17 12.07 CCND1 CDKN1A IL2 IL6
18
Show member pathways
12.04 BCL2 CCND1 CDKN1A
19 12.03 CCND1 CDKN1A IL6
20 12.01 CCND1 CDKN1A IL6
21 11.99 BCL2 CCND1 CDKN1A
22
Show member pathways
11.97 CCND1 CDKN1A IL6
23
Show member pathways
11.94 CCND1 CDKN1A IL6
24
Show member pathways
11.87 BCL2 CDKN1A IL2 IL6
25 11.86 CCND1 IL2 IL6
26 11.84 BCL2 CCND1 CDKN1A
27 11.79 BCL2 CDKN1A IL6
28 11.76 BCL2 CDKN1A IL6
29 11.75 BCL2 CCND1 IL6
30
Show member pathways
11.72 BCL2 CCND1 CDKN1A IL2 IL6
31 11.71 BCL2 CCND1 CDKN1A
32 11.64 CDKN1A IL2 IL6
33 11.59 BCL2 CCND1 CDKN1A
34 11.51 BCL2 CCND1 CDKN1A IL6
35
Show member pathways
11.49 B2M IL2
36
Show member pathways
11.49 CCND1 IL2 IL6
37 11.44 BCL2 CCND1 CDKN1A
38 11.4 CCND1 CDKN1A
39 11.37 BCL2 CCND1 IL6
40 11.36 BCL2 CDKN1A
41 11.34 CCND1 CDKN1A
42 11.25 CCND1 CDKN1A IL6
43 11.23 CCND1 IL6
44 11.22 CCND1 IL6
45 11.18 CCND1 CDKN1A
46 11.14 IL2 IL6
47 11.08 BCL2 IL2
48 11.07 BCL2 IL2 IL6
49
Show member pathways
11.01 BCL2 CDKN1A
50 10.93 BCL2 IL6

GO Terms for Extramedullary Plasmacytoma

Cellular components related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cyclin-dependent protein kinase holoenzyme complex GO:0000307 8.62 CCND1 CDKN1A

Biological processes related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

(show all 21)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of apoptotic process GO:0043066 9.67 BCL2 CDKN1A IL2 IL6
2 positive regulation of cell proliferation GO:0008284 9.62 BCL2 CCND1 IL2 IL6
3 positive regulation of T cell proliferation GO:0042102 9.6 IL2 IL6
4 humoral immune response GO:0006959 9.59 BCL2 IL6
5 negative regulation of G1/S transition of mitotic cell cycle GO:2000134 9.58 BCL2 CDKN1A
6 regulation of cyclin-dependent protein serine/threonine kinase activity GO:0000079 9.58 CCND1 CDKN1A
7 animal organ regeneration GO:0031100 9.57 CCND1 CDKN1A
8 cellular response to organic substance GO:0071310 9.56 BCL2 CCND1
9 positive regulation of B cell proliferation GO:0030890 9.55 BCL2 IL2
10 T cell differentiation GO:0030217 9.54 BCL2 IL2
11 response to organonitrogen compound GO:0010243 9.52 CCND1 CDKN1A
12 extrinsic apoptotic signaling pathway in absence of ligand GO:0097192 9.51 BCL2 IL2
13 response to steroid hormone GO:0048545 9.49 BCL2 CCND1
14 T cell differentiation in thymus GO:0033077 9.48 B2M BCL2
15 response to X-ray GO:0010165 9.46 CCND1 CDKN1A
16 response to drug GO:0042493 9.46 B2M BCL2 CCND1 CDKN1A
17 response to corticosterone GO:0051412 9.43 CCND1 CDKN1A
18 response to iron ion GO:0010039 9.4 BCL2 CCND1
19 cytokine-mediated signaling pathway GO:0019221 9.35 BCL2 CCND1 CDKN1A IL2 IL6
20 positive regulation of immunoglobulin secretion GO:0051024 9.26 IL2 IL6
21 response to glucocorticoid GO:0051384 8.92 BCL2 CCND1 CDKN1A IL6

Sources for Extramedullary Plasmacytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....